Anvisa aprova nova indicação terapêutica para o Botox

Imported from official source

Toxina botulínica passa as ser indicada para o tratamento de hipertrofia benigna do músculo responsável pela mastigação

This version

Version
1 of 1
Recorded
November 16, 2026 17:01
Change
Initial
Content hash
87f7b329ff9d9a7bbb6452ed1482e742
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.